|
SUSD1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.58609833337209E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.0435999559254E-09 |
| Normal-vs-Stage2 |
3.382000E-04 |
| Normal-vs-Stage3 |
9.79250003307897E-09 |
| Normal-vs-Stage4 |
2.14519957353332E-10 |
| Stage1-vs-Stage2 |
4.604200E-01 |
| Stage1-vs-Stage3 |
1.714840E-01 |
| Stage1-vs-Stage4 |
5.779300E-04 |
| Stage2-vs-Stage3 |
9.815800E-02 |
| Stage2-vs-Stage4 |
2.038700E-03 |
| Stage3-vs-Stage4 |
3.471600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.12959658188561E-11 |
| Normal-vs-AfricanAmerican |
1.73490999999526E-05 |
| Normal-vs-Asian |
5.772900E-04 |
| Caucasian-vs-AfricanAmerican |
2.743000E-01 |
| Caucasian-vs-Asian |
3.666600E-01 |
| AfricanAmerican-vs-Asian |
2.815000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.94222415927925E-12 |
| Normal-vs-Female |
1.353830E-04 |
| Male-vs-Female |
4.758900E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.77180000000244E-05 |
| Normal-vs-Extreme_Weight |
4.8323001156092E-10 |
| Normal-vs-Obese |
1.00129999958121E-07 |
| Normal-vs-Extreme_Obese |
4.402800E-04 |
| Normal_Weight-vs-Extreme_Weight |
1.634640E-01 |
| Normal_Weight-vs-Obese |
7.480600E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.604000E-01 |
| Extreme_Weight-vs-Obese |
1.942240E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.976800E-01 |
| Obese-vs-Extreme_Obese |
5.913400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.76039998928724E-09 |
| Normal-vs-Age(41-60Yrs) |
4.29610014229809E-10 |
| Normal-vs-Age(61-80Yrs) |
4.60610000141415E-08 |
| Normal-vs-Age(81-100Yrs) |
1.56015999999148E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.864100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.942300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.677600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.616200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.845800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.723620E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.19869999481992E-08 |
| Normal-VS-Type2 PRCC |
2.23440000002295E-06 |
| Normal-VS-KIRP CIMP |
3.54820000000311E-05 |
| Normal-VS-Unclassified PRCC |
1.805820E-04 |
| Type1 PRCC-VS-Type2 PRCC |
1.937190E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.176200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.480200E-03 |
| Type2 PRCC-VS-KIRP CIMP |
7.423900E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.291800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.883700E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.63979949011173E-10 |
| Normal-vs-N1 |
5.22639997946328E-09 |
| Normal-vs-N2 |
2.956000E-02 |
| N0-vs-N1 |
6.185800E-01 |
| N0-vs-N2 |
6.176400E-01 |
| N1-vs-N2 |
3.794600E-01 |
|
|
